| Cell cycle |
10 |
1.80E-10 |
MCM2; MCM7; PKMYT1; CDK2; GADD45B; MAD2L2; TFDP1; GADD45A; PCNA; ORC1L |
| Apoptosis |
8 |
7.26E-09 |
IRAK2; NFKBIA; BCL2L1; TNFRSF10B; BAX; DFFA; EXOG; TNF |
| Purine metabolism |
8 |
4.74E-07 |
ADA; ADCY3; ADCY8; POLA1; POLR3K; POLE2; GART; DGUOK |
| MAPK signaling |
8 |
3.71E-05 |
MAP3K8; GADD45B; DUSP2; ATF4; GADD45A; DUSP5; TNF; DUSP10 |
| Cytokine-cytokine receptor interaction |
7 |
1.92E-04 |
TNFSF9; TNFRSF10B; CD70; IL8; TNF; TNFRSF18; TNFSF13B |
| DNA polymerase |
5 |
5.76E-07 |
MCM2; MCM7; POLA1; PCNA; POLE2 |
| Base excision repair |
5 |
5.76E-07 |
PARP2; PCNA; POLE2; APEX2; POLB |
| Adipocytokine signaling |
5 |
1.32E-05 |
SOCS3; NFKBIA; TNF; NFKBIE; CPT1A |
| p53 signaling |
5 |
1.52E-05 |
CDK2; GADD45B; TNFRSF10B; BAX; GADD45A |
| Epithelial cell signaling in H.pylori infection |
5 |
1.63E-05 |
NFKBIA; LYN; IL8; JAM2; SRC |
| Small cell lung cancer |
5 |
4.44E-05 |
NFKBIA; BCL2L1; CDK2; TRAF3; TRAF4 |
| Toll-like receptor signaling |
5 |
1.00E-04 |
NFKBIA; MAP3K8; IL8; TNF; TRAF3 |
| One carbon pool by folate |
4 |
6.80E-07 |
SHMT2; GART; MTHFS; MTHFD1L |
| Urea cycle andmetabolism of amino groups |
4 |
7.33E-06 |
ASS1; ACY1; ALDH7A1; SMS |
| Aminoacyl-tRNA biosynthesis |
4 |
3.46E-05 |
WARS; YARS; GARS; RARS |
| Glycine, serine and threonine metabolism |
4 |
4.19E-05 |
CBS; PHGDH; SHMT2; GARS |
| Gap junction |
4 |
8.33E-04 |
ADCY3; ADCY8; CSNK1D; SRC |
| Pyrimidine metabolism |
4 |
8.33E-04 |
UPP1; POLA1; POLR3K; POLE2 |
| GnRH signaling |
4 |
0.00140 |
ADCY3; ADCY8; ATF4; SRC |
| T cell receptor signaling |
4 |
0.00150 |
NFKBIA; MAP3K8; TNF; NFKBIE |
| Tight junction |
4 |
0.00335 |
CGN; MYL2; JAM2; SRC |
| Insulin signaling |
4 |
0.00353 |
TRIP10; SOCS3; PFKM; PTPN1 |
| Mismatch repair |
3 |
1.46E-04 |
MSH6; PCNA; EXO1 |
| Arginine and proline metabolism |
3 |
5.66E-04 |
ASS1; PYCR1; RARS |
| Nucleotide excision repair |
3 |
0.00102 |
ERCC1; PCNA; POLE2 |
| Fatty acid metabolism |
3 |
0.00109 |
ACADVL; ALDH7A1; CPT1A |
| Glutathione metabolism |
3 |
0.00148 |
GSTA4; GGCT; SMS |
| Inositol phosphate metabolism |
3 |
0.001952 |
IMPA2; INPP1; ITPKA |
| Amyotrophic lateral sclerosis |
3 |
0.002056 |
BCL2L1; BAX; TNF |
| Hedgehog signaling |
3 |
0.002163 |
CSNK1E; CSNK1D; RAB23 |
| Glycolysis/Gluconeogenesis |
3 |
0.003010 |
ALDH7A1; PFKM; GCK |
| Drug metabolism cytochrom.p450 |
3 |
0.00419 |
GSTA4; FMO4; CYP3A5 |
| B-cell receptor signaling |
3 |
0.0047 |
NFKBIA; LYN; NFKBIE |
| Chronic myeloid leukemia |
3 |
0.0047 |
NFKBIA; BCL2L1; STAT5A |
| Phosphatidylinositol signaling |
3 |
0.0048 |
IMPA2; INPP1; ITPKA |
| Prostate cancer |
3 |
0.0073 |
NFKBIA; CDK2; ATF4 |
| NK cell mediated cytotoxicity |
3 |
0.0243 |
TNFRSF10B; ULBP1; TNF |
| Jak-STAT signaling |
3 |
0.0327 |
SOCS3; BCL2L1; STAT5A |
| Calcium signaling |
3 |
0.0501 |
ADCY3; ADCY8; ITPKA |
| Focal adhesion |
3 |
0.0649 |
MYL2; SRC; PARVB |
